Ian Read

Type: Person
Name: Ian Read
Title: Assistant Commissioner, SB - Hurtsville (Australia)
First reported 4 hours ago - Updated 4 hours ago - 1 reports

Pfizer hit by Viagra patent expiration

The expiration of US pharmaceutical company Pfizer’s patent for Viagra in many European countries was a contributing factor to the drop in revenue that it reported yesterday (July 29) when releasing its second-quarter earnings data.The company’s revenue ... [Published World Intellectual Property Review - 4 hours ago]
Entities: Viagra, Pfizer Inc, Patent
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Wall Street Breakfast: GM Faces New Ignition Switch Lawsuit

EconomyThe Fed is likely to go forward with its plan to wind down its bond-buying stimulus today, cutting its monthly asset purchases to $25B from $35B - on target for shutting the program this fall. During the Fed's announcement, investors will be looking ... [Published Seeking Alpha - 6 hours ago]
First reported 14 hours ago - Updated 8 hours ago - 1 reports

03:37 Pfizer leaves investors guessing on intentions for Astra

The largest U.S. drugmaker reported higher-than-expected second-quarter revenue, helped by growing demand for its cancer medicines. But overall sales fell on competition with newer rival drugs and cheaper generics, trends that have quickened Pfizer’s ... [Published NewsRT.co.uk - 14 hours ago]
First reported 23 hours ago - Updated 8 hours ago - 4 reports

Pfizer still set on tax inversion

04:49 ET | About: Pfizer Inc. (PFE)Pfizer (NYSE:PFE) is still looking to complete it highly desired tax inversion, despite AstraZeneca's rejection of its £69.4B takeover bid in May.CEO Ian Read is lobbying in Washington for an overhaul of tax rules which ... [Published Seeking Alpha - 8 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 1 reports

Pfizer net earnings dips by 79% in Q2 to $2,912 million

Pfizer Inc, a second largest pharmaceutical company in the world after Novartis, has suffered heavy setback during the second quarter ended June 2014 on account of one time income received from sell of animal health business, Zoetis Inc.,  for a consideration ... [Published PharmaBiz - 9 hours ago]
First reported Jul 29 2014 - Updated 17 hours ago - 17 reports

Pfizer set to launch a second attempt to buy AstraZeneca

Pfizer is likely to launch a second attempt to buy AstraZeneca despite reporting a poor set of financial figures.Profits at the US drugs giant fell by 25 per cent in the first half of the year, and it was unable to announce any new blockbuster drugs.The ... [Published This Is Money - 19 hours ago]
First reported Jul 29 2014 - Updated 20 hours ago - 1 reports

Pfizer Q2 adjusted earnings beat Street estimates

Pfizer (PFE), a leading global drug maker, has recorded 79.34 percent plunge in profit for the quarter ended Jun. 30, 2014. The company earned $2,912 million or $0.45 a share in the second-quarter compared with $14,095 million or $1.98 a share a year ... [Published MyIris - Jul 29 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 2 reports

Pfizer rallies 1.4% in pre-market after upbeat Q2 earnings

Investing.comInvesting.com - U.S. pharmaceutical giant Pfizer (NYSE:PFE) reported better-than-expected second quarter earnings ahead of Tuesday’s opening bell, sending its shares higher in pre-market trade.Pfizer said adjusted earnings per share came ... [Published Jerusalem Post - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 29 2014 - 1 reports

The Pfizer dilemma: Spurned by AstraZeneca, revenue falling and facing an R&D crisis

Pfizer is in a nasty fix. Tomorrow the pharma giant ($PFE) will release a rundown of its Q2 numbers--which won't be pretty--and CEO Ian Read and his top team will have plenty of explaining to do about how they plan to get out of the tight spot they find ... [Published FierceBiotech - Jul 28 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Bottom Line: AbbVie succeeds where Pfizer has failed

HOW PFIZER’S chief executive Ian Read must be looking enviously at his US pharmaceutical counterpart Rick Gonzalez this morning.Read, you'll remember, was the plucky Scot hauled over to the UK by MPs into a blaze of publicity about his dastardly plan ... [Published City A.M. - Jul 15 2014]
First reported Jul 04 2014 - Updated Jul 04 2014 - 1 reports

FirstWord List – The key pharma trends of 2014 to date...

With the football (soccer) World Cup entering its pivotal stages in Brazil, it is perhaps appropriate to consider 2014 to date as a game of two halves for the pharmaceutical industry – or its shareholders at least.Sovaldi brings US drug pricing to the ... [Published FirstWord Pharma - Jul 04 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 3 reports

Pfizer elects new board member

(MarketLine via COMTEX News Network) -- Pfizer Inc., a biopharmaceutical company, has elected James Smith to the board of directors.Mr Smith also was appointed to the Corporate Governance and Science and Technology Committees of Pfizer's Board.Mr Smith, ... [Published PredictWallStreet - Jul 02 2014]

Quotes

...full value for AstraZeneca based on the information that was available to us," Ian Read, chairman and CEO of PFE said in a May press release. "as we said from the start, the pursuit of this transaction was a potential enhancement to our existing strategy."

More Content

All (302) | News (233) | Reports (0) | Blogs (63) | Audio/Video (2) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Pfizer Scores Vaccine Expansion with Baxter’s P... [Published The Utah People's Post - 1 hour ago]
Many Americans can't afford Obamacare: Aetna CEO [Published CNBC - 1 hour ago]
Pfizer hit by Viagra patent expiration [Published World Intellectual Property Review - 4 hours ago]
Wall Street Breakfast: GM Faces New Ignition Sw... [Published Seeking Alpha - 6 hours ago]
Pfizer still set on tax inversion [Published Seeking Alpha - 8 hours ago]
Pfizer net earnings dips by 79% in Q2 to $2,912... [Published PharmaBiz - 9 hours ago]
03:37 Pfizer leaves investors guessing on inten... [Published NewsRT.co.uk - 14 hours ago]
Pfizer set to launch a second attempt to buy As... [Published This Is Money - 19 hours ago]
Pfizer Sticking To “Plan A,” But Read Says That... [Published Health News Daily - 19 hours ago]
Merck (MRK) Shares Rise, Pfizer (PFE) Stock Slu... [Published Money Morning - 20 hours ago]
Pfizer CEO says company "aggressively" seeking ... [Published FirstWord Pharma - 20 hours ago]
Pfizer Still Looking to Buy; Results Beat Views... [Published Capital.gr - 20 hours ago]
Pfizer leaves investors guessing on intentions ... [Published Yahoo! Malaysia - 20 hours ago]
UPDATE 3-Pfizer leaves investors guessing on in... [Published Reuters UK - 21 hours ago]
Pfizer chief says shareholders supportive of de... [Published Seeking Alpha - 21 hours ago]
Pfizer defends £69bn move for AstraZeneca [Published Telegraph - 22 hours ago]
Pfizer : Still Looking to Buy; Results Beat Vie... [Published 4 Traders - 22 hours ago]
Pharma CEOs talk tax 'inversions' [Published Wall Street Business Network - 23 hours ago]
Pfizer CEO Still Hunting for Deals and Willing ... [Published FirstWord Pharma - 23 hours ago]
Pfizer leaves investors guessing on intentions ... [Published FirstWord Pharma - 23 hours ago]
Pharma CEOs: Tax system flaws help overseas rivals [Published CNBC - 23 hours ago]
Pfizer earnings drop less than expected (AFP) [Published West Australian - 23 hours ago]
Pharma CEOs: Tax system flaws help overseas rivals [Published Atlanta Journal And Constitution - 23 hours ago]
Pfizer leaves investors guessing on intentions ... [Published NewsRT.co.uk - Jul 29 2014]
Earnings at Pfizer tank but still just beat exp... [Published Pharma Letter - Jul 29 2014]
Video: Pfizer CEO to CNBC: Tax reform would bri... [Published NBCNews.com - Jul 29 2014]
AstraZeneca : Pfizer leaves investors guessing ... [Published 4 Traders - Jul 29 2014]
Beyond the Q2 numbers, three big questions for ... [Published FiercePharma - Jul 29 2014]
Pfizer Q2 adjusted earnings beat Street estimates [Published MyIris - Jul 29 2014]
Pfizer Inc. Beats Q2 Estimates; Narrows FY Outl... [Published Dividend.com - Jul 29 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Pfizer Decides AstraZeneca Isn’t Worth the Trou... [Published Wall St. Cheat Sheet - May 27 2014]
Source: Thinkstock After months of the chase, it seems Pfizer Inc.  ( NYSE:PFE ) has finally given up on its pursuit of British-Swedish drugmaker AstraZeneca Group Plc  ( NYSE:AZN ). The company announced in a statement on Monday that it would ...
Frontrunning: May 27 [Published Zero Hedge - May 27 2014]
Vietnam, China trade accusations after Vietnamese fishing boat sinks ( Reuters ) SEC Set to Spur Exchange Trading ( WSJ ) Bank of Japan quietly eyes stimulus exit ( Reuters ) Japan Risks Low Growth Even as Easing Spurs Inflation ( BBG ) Hello Japan: Bond ...
Pfizer ditches pursuit of AstraZeneca [Published AdBanks.net - May 27 2014]
Pfizer has dropped its pursuit of AstraZeneca after repeated takeover attempts. br /> Pfizer has given up on its attempt to take over the British pharmaceutical company AstraZeneca. The American drug maker announced Monday that it was withdrawing ...
Pfizer abandons AstraZeneca takeover plans [Published Proactiveinvestors United Kingdom website - May 27 2014]
US drugmaker Pfizer has confirmed it has no plans to launch another bid for rival AstraZeneca ( LON:AZN ). The London-listed Anglo-Swedish group rejected the final £55 a share (£69bn) bid despite some of the firm’s most influential shareholders urging ...
Decentralising drug research: Pharmed out [Published The Economist - Business - May 22 2014]
IAN READ, the chief executive of Pfizer, is not a man easily rebuffed. His attempt to woo AstraZeneca, a British drugs firm, included politesse—appearances before Parliament, web videos on Pfizer’s strategy—and, more importantly, a sweetened offer ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
UK MPs quiz Pfizer boss over Astra [Published Reuters Video: Business - May 13 2014]
Pfizer to mount UK charm offensive [Published Reuters Video: Business - May 09 2014]
1

Press Releases

sort by: Date | Relevance
ASTRAZENECA BOARD REJECTS PFIZER’S FINAL PROPOSAL [Published AstraZeneca - May 19 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.